Commentary on: Kunz, A., Ebinger, M., Geisler, F., Rozanski, M., Waldschmidt, C., Weber, J.E., Wendt, M., Winter, B., Zieschang, K., Fiebach, J.B. and Villringer, K., 2016. Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry study. The Lancet Neurology, 15(10), pp.1035-1043

Autor: Grunwald, Iris Q.

Publikováno v: Cardiology PracticeUpdate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::2305bfb00007694ce57b7490b09ff544
https://arro.anglia.ac.uk/id/eprint/700741/1/Grunwald_2016_CardiologyPracticeUpdate.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Excited state absorption spectroscopy of [formula omitted] glass — Experiment and simulation

Autor: Piatkowski, D., Wisniewski, K., Rozanski, M., Koepke, Cz.

Publikováno v: In Physics Procedia August 2009 2(2):365-372

Discriminative value of glial fibrillar acidic protein (GFAP) as a diagnostic tool in acute stroke. Individual patient data meta-Analysis

Autor: Cabezas, J.A. Bustamante, A. Giannini, N. Pecharroman, E. Katsanos, A.H. Tsivgoulis, G. Rozanski, M. Audebert, H. Mondello, S. Llombart, V. Montaner, J.

Glial fibrillar acidic protein (GFAP) in serum has been evaluated as a promising biomarker to differentiate between intracerebral hemorrhage (ICH) and acute ischemic stroke (AIS). We assessed its value as diagnostic and prognostic tool for ICH throug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::842ddbcd0d008a9ff2a27529650b69ba
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3078460

Pre-existing Reactivity to an IgG4 Fc-Epitope: Characterization and Mitigation of Interference in a Bridging Anti-drug Antibody Assay.

Autor: Partridge MA; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA. michael.partridge@regeneron.com., Chen J; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Karayusuf EK; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Sirimanne T; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Stefan C; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Lai CH; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Gathani M; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., DeStefano L; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Rozanski M; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., McAfee S; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Rajadhyaksha M; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.; Alexion-AstraZeneca Rare Disease Unit, 100 College St, New Haven, CT, 06510, USA., Andisik MD; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Torri A; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA., Sumner G; Bioanalytical Sciences, Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY, 10591, USA.

Publikováno v: The AAPS journal [AAPS J] 2022 Jul 01; Vol. 24 (4), pp. 78. Date of Electronic Publication: 2022 Jul 01.